Αρχική World News Altering Diet Enhances Response to Cancer Treatments in Mice

Altering Diet Enhances Response to Cancer Treatments in Mice

, by NCI Staff

Illustration of a damaged DNA double helix.

A diet low in methionine, a nutrient cells need to repair DNA damage, may make therapies like chemotherapy more effective.

Credit: iStock

People must eat to survive. And the cells that make up the body eat too. Or more accurately, cells break down and rebuild food into the individual molecules they need to stay alive and grow. This complex network of processes is called cellular metabolism.

Cancer cells can alter their metabolism to survive, so targeting cancer cell metabolism has become of great interest to researchers. Questions being asked include: Is it possible to attack a tumor’s nutritional needs as part of cancer treatment? And could this be done by tweaking a cancer patient’s diet?

A new NCI-supported study suggests that the latter may be possible. In the study, researchers showed that feeding mice a diet very low in the nutrient methionine improved the ability of chemotherapy and radiation therapy to shrink tumors.

When the researchers tested a low methionine diet in six healthy adults, methionine levels in their bodies fell and they experienced metabolic changes similar to those seen in the mouse studies. However, the study was not designed to test the effect of methionine restriction on cancer treatment in humans.

The concept of using specific dietary changes to enhance cancer treatment “is really at the very early stages,” said Jason Locasale, Ph.D., of Duke University, who led the new study. “And there’s not going to be one be-all, end-all diet for [treating] cancer. But these aspects of diet seem to have all kinds of really interesting effects on cancer outcomes, and we have to take them seriously.”

A Dietary Vulnerability

Methionine is an essential amino acid that plays an important role in cellular metabolism. The body cannot produce methionine from scratch, so it must come from food. Methionine is most prevalent in animal products, such as lean meat and eggs, but also can be found in lower quantities in plant sources.

Normal cells can also recycle methionine that has already been taken into the body, explained Michael Espey, Ph.D., of NCI’s Division of Cancer Biology, who was not involved in the study. But some cancer cells lose this ability when they mutate, he added. This means that they become completely reliant on the diet for their methionine requirements.

Methionine is needed by cells to repair damaged DNA and reduce oxidative stress, Dr. Espey explained. So depleting methionine from cancer cells targeted by DNA-damaging therapies, such as chemotherapy or radiation therapy, “may enhance the ability of these treatments to kill the cancer cells,” he said.

“Cancer researchers recognized this feature and surmised that methionine could be a potential weakness, because anything that a cancer cell has become reliant on is a good target, as long as you have some sort of treatment to attack that vulnerability,” said Dr. Espey.

In their study, Dr. Locasale and his colleagues first measured whether cutting the amount of methionine in the diet of mice could quickly reduce the amount of methionine available to cells in the body. They found that switching mice to a diet about seven times lower in methionine than normal reduced the levels in cells after 2 days.

They then fed the low methionine diet to mice carrying tumors derived from either of two types of human cancer cells. Methionine restriction alone greatly slowed the growth of tumors derived from one of the cell lines, and slowed it somewhat in tumors derived from the other cell line.

Enhancing Treatment Effects

The researchers next tested whether adding dietary methionine restriction to cancer treatments in mice could magnify the effects of those treatments.

In mice bearing tumors derived from human colorectal cancer, low doses of the DNA-damaging chemotherapy drug 5-fluorouracil (5-FU) failed to shrink the tumors. But when the mice were fed the methionine-restricted diet during 5-FU treatment, their tumors shrank. Analyses of metabolism showed that the production of molecules needed to repair DNA, which requires methionine, had been altered as expected.

The researchers also tested the combination of methionine restriction and radiation therapy in mice engineered to grow aggressive soft tissue sarcomas. The combination of the methionine-restricted diet plus radiation therapy slowed tumor growth by about 50% compared with the combination of a normal diet plus radiation.

More Knowledge Needed

In a proof-of-concept follow-up experiment, six healthy middle-aged adults were recruited to eat a low methionine diet for 3 weeks. The diet contained about 80% less methionine than an average normal diet. Protein was mainly supplied through a methionine-free dietary supplement. The diet also included fruits, vegetables, and refined grains, which are naturally low in methionine.

In the human study, the low methionine diet quickly reduced the amount of the amino acid available to participants’ cells and altered the cells’ metabolism, similar to what the researchers had observed in mice fed a methionine-restricted diet.

Methionine restriction “is a potential strategy” to treat cancer, Dr. Espey said. “But more research is needed into the correct dose and timing, and the amount of restriction that’s necessary to balance the positive effects on enhancing cancer therapy versus the negative effects on the body’s normal physiology.” 

Among other things, methionine is needed to maintain nerve cells and muscle mass, he added. “So there could potentially be side effects of restricting methionine in the diet [in the long term].”

“We can speculate that there’s going to be all kinds of interesting nutritional interventions that could influence cancer, but we’re nowhere near the point of really being able to prescribe these dietary interventions,” added Dr. Locasale.

For other diseases where metabolism is known to play an important role—such as cardiovascular disease and diabetes—dietary interventions are an important part of treatment, Dr. Locasale said.

“Over the last 10-15 years, we’ve come to understand that cancer also has a huge metabolic component to it,” he continued. “Cancer cells have different nutrient requirements and different metabolic demands than normal tissue. But we have almost no knowledge of how nutrition might influence demands. We’re just starting [to learn] right now.”



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

FDA Approves Companion Diagnostic to Identify NTRK Fusions in Solid Tumours for Larotrectinib

On 23 October 2020, the US Food and Drug Administration (FDA) approved the next-generation sequencing (NGS)-based FoundationOne CDx test (Foundation Medicine, Inc.) as a...

An existing blood test for ovarian cancer has been re-evaluated. The results are in.

Ovarian cancer is the sixth most common cancer in women in the UK, with about 7,400 new cases every year. This number equates to...

Teacher Is Glad She Asked for More Testing After Mammogram Failed to Detect Her Breast Cancer

Martha Gray has a long history of breast cancer in her family, so she knows that she needs to take her mammograms seriously every...

How to Stay Healthy After Cancer

I try to pack helpful advice into every follow-up visit I have with patients, focusing on little tips that help foster healthy lifestyles. This...

Feasibility and Preliminary Efficacy Results of the Beat AML Study

Precision medicine in acute myeloid leukaemia (AML) is feasible in terms of providing cytogenetic and mutational data within 7 days, allowing their rapid incorporation into...

Woman Battles Breast Cancer While Pregnant, Delivers Healthy Baby Boy

When she was six months pregnant, Desiree Doughty noticed that something seemed to be wrong with her breasts. “I noticed that one of my breasts...